Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.

doi:10.1016/0046-8177(93)90080-z

Back to search

Article

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.

Human pathology - 1 Apr 1993

Brown R W, Clark G M, Tandon A K, Allred D C

Abstract excerpt

The diagnostic distinction between malignant pleural epithelial mesothelioma and pulmonary adenocarcinoma is often difficult and partially reliant on the use of immunohistochemistry (IHC). While there are several available IHC markers preferentially expressed in adenocarcinomas compared with meso...

Topics

Adenocarcinoma
Amylases
Biomarkers, Tumor
Diagnosis, Differential
Histocytochemistry
Humans
Immunohistochemistry
Lung Neoplasms
Mesothelioma
Periodic Acid-Schiff Reaction
Phenotype
Pleural Neoplasms
Staining and Labeling

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.